The Food and Drug Administration has made the approval of GlaxoSmithKline's rotavirus vaccine all but official, having its advisory panel vote in favor of the vaccine...
Six-month IXCHIQ chikungunya vaccine data demonstrates sustained antibody levels
Six-month results from the phase 2 VLA1553-221 trial aligned with initial data and demonstrated immune response at day 180 among patients aged 1 to 11 years.
Food Insecurity and the Dangers of Infant Formula Dilution
Expanded prenatal panel targets broader genetic risk in diverse pregnancies
Unlike conventional carrier screening that estimates generic reproductive risk, the UNITY panel offers a direct fetal risk estimate.
Demystifying Infant Formula
Study: Even low lead exposure in early childhood tied to academic decline
Children with blood lead levels below CDC intervention thresholds had lower test scores through adolescence, a new study showed.
FDA approves pediatric indication for SONU wearable device to treat nasal congestion
The AI-enabled, wearable device is the first FDA-approved, drug-free solution for nasal congestion and allergies in children ages 12 and up.